Liu et al v. BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al
| Li Liu and Dr. Emily Liu |
| BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and Boehringer Ingelheim International GMBH |
| Judge Marianne B. Bowler |
| 1:2014cv13234 |
| August 5, 2014 |
| US District Court for the District of Massachusetts |
| Boston Office |
| Barnstable |
| William G Young |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 Diversity-Personal Injury |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 9, 2017. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 168 Judge William G. Young: ORDER entered. SETTLEMENT ORDER OF DISMISSAL. (Gaudet, Jennifer) |
| Filing 167 Judge William G. Young: ELECTRONIC ORDER entered granting #166 MOTION for Leave to File Reply Brief in Support of Defendants' Motion in Limine No. 7 to Exclude Evidence or Argument Concerning Preempted Claims Relating to "Black Box" Warnings and Contraindications (Unopposed) ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
| Filing 166 MOTION for Leave to File Reply Brief in Support of Defendants' Motion in Limine No. 7 to Exclude Evidence or Argument Concerning Preempted Claims Relating to "Black Box" Warnings and Contraindications (Unopposed) by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation.(Jones, Phyllis) |
| Filing 165 Opposition re #136 MOTION in Limine No. 7 to Exclude Evidence or Argument Concerning Preempted Claims Relating to "Black Box" Warnings and Contraindications filed by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(Lurie, Michael) |
| Filing 164 Judge William G. Young: ELECTRONIC ORDER entered re #161 MOTION in Limine # 5 (Renewed) re Deposition Testimony of BI Employees in CT Pradaxa Litigation.Motion allowed as to Exhibit B starting with the testimony elicited by Mr. Perkins at p.161 line 6 through line 20 as well as the answers beginning on page 191 through page 192 line 14 and page 209 line 6 through line 9 and page 222 line 8 and page 224 line 2. Motion denied as to the remainder as the testimony is immaterial to the narrow issue before the Court. The plaintiffs are not, however, to be denied the ability to proffer relevant contemporaneous evidentiary admissions BI may counter designate solely for the sake of completeness. (Paine, Matthew) |
| Filing 163 Judge William G. Young: ELECTRONIC ORDER entered re #100 MOTION in Limine No. 4 to Exclude the Expert Testimony of Dr. Walter J. Molofsky.MOTION DENIED. On the narrow issue to be tried in this case, Dr. Molofsky may testify. (Paine, Matthew) |
| Filing 162 Opposition re #161 MOTION in Limine # 5 (Renewed) re Deposition Testimony of BI Employees in CT Pradaxa Litigation filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Jones, Phyllis) |
| Filing 161 MOTION in Limine # 5 (Renewed) re Deposition Testimony of BI Employees in CT Pradaxa Litigation by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B)(Lurie, Michael) |
| Filing 160 MOTION in Limine No. 8 to Exclude Evidence of Bereavement Damages by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation.(Flanagan, William) |
| Filing 159 Judge William G. Young: ELECTRONIC ORDER entered re #152 MOTION in Limine #5 FOR LEAVE TO DESIGNATE VIDEOTAPED DEPOSITION TESTIMONY GIVEN BY BOEHRINGER INGELHEIM EMPLOYEE WITNESSES AT DEPOSITIONS RECENTLY TAKEN IN THE CONNECTICUT CONSOLIDATED PRADAXA LITIGATION.Denied without prejudice to its renewal supported by the transcript of the testimony sought to be admitted. (Paine, Matthew) |
| Filing 158 MEMORANDUM in Opposition re #152 MOTION in Limine #5 FOR LEAVE TO DESIGNATE VIDEOTAPED DEPOSITION TESTIMONY GIVEN BY BOEHRINGER INGELHEIM EMPLOYEE WITNESSES AT DEPOSITIONS RECENTLY TAKEN IN THE CONNECTICUT CONSOLIDATED PRADAXA LITIGATION filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A)(Jones, Phyllis) |
| Filing 157 Judge William G. Young: ELECTRONIC ORDER entered. re #147 Letter Requesting Clarification on 145 Court's Ruling on Plaintiffs' Motion in Limine No. 2. MOTION DENIED. The Court needs no further briefing. This is a matter of basic trial administration. All parties will offer to produce live any witness where deposition has been taken upon pain of being barred from calling that witness. I am surprised counsel did not work this out among themselves. (Paine, Matthew) |
| Filing 156 Judge William G. Young: ELECTRONIC ORDER entered re #119 MOTION in Limine No. 6 to Exclude Testimony of Plaintiffs' Untimely Disclosed Witnesses and Limit Deposition Designations. These three witnesses are in no sense recently discovered. As the plaintiffs response makes clear, they were discovered in the course of reasonable trial preparation - preparation which ought have taken place earlier in accordance with the Court's orders. Still, excluding relevant evidence is too drastic a remedy. Instead, as an appropriate sanction, the direct testimony of these three witnesses shall take - in the aggregate - no more than 30 minutes. (Paine, Matthew) |
| Filing 155 Judge William G. Young: ELECTRONIC ORDER entered re #141 MOTION in Limine # 3 FOR THE IMPOSITION OF SANCTIONS STEMMING FROM DEFENDANTS EXTRAORDINARY DISCOVERY MISCONDUCT. Motion denied without prejudice to arguing for a spoilation instruction in the final charge. (Paine, Matthew) |
| Filing 154 Judge William G. Young: ELECTRONIC ORDER entered re #105 MOTION in Limine No. 5 to Exclude Evidence of Irrelevant Company Conduct, Litigation, and Financial Matters.Motion allowed to the extent of forbidding the plaintiffs from adverting to any of these matters in opening. Beyond that the Court expresses no opinion. We will see how the case develops. (Paine, Matthew) |
| Filing 153 Judge William G. Young: ELECTRONIC ORDER entered re #142 Fourth MOTION in Limine to admit the Past Recollection Recorded Video Testimony of Dr. Julia Song.The following portions of the December 4, 2014 video interview may be played at the plaintiffs option - "I am very happy...We just meet [to the conclusion of the interview where she is crying]" (Paine, Matthew) |
| Filing 152 MOTION in Limine #5 FOR LEAVE TO DESIGNATE VIDEOTAPED DEPOSITION TESTIMONY GIVEN BY BOEHRINGER INGELHEIM EMPLOYEE WITNESSES AT DEPOSITIONS RECENTLY TAKEN IN THE CONNECTICUT CONSOLIDATED PRADAXA LITIGATION by Emily Liu, Li Liu.(Lurie, Michael) |
| Filing 151 Judge William G. Young: ELECTRONIC ORDER entered: Motion denied as unnecessary re #146 Motion for Hearing (Paine, Matthew) |
| Filing 150 Judge William G. Young: ELECTRONIC ORDER entered granting #98 MOTION in Limine No. 3 to Exclude Evidence or Argument Related to Pradaxa's Initial Lack of a Reversal Agent and Subsequent Approval of a Reversal Agent. (Paine, Matthew) |
| Filing 149 Judge William G. Young: ELECTRONIC ORDER entered granting #97 MOTION in Limine No. 2 to Exclude Argument and Evidence Related to Pradaxa Blood Plasma Concentrations (Paine, Matthew) |
| Filing 148 Judge William G. Young: ELECTRONIC ORDER entered granting #96 MOTION in Limine No. 1 to Exclude Evidence Related to the 110 Milligram Dose of Pradaxa (Paine, Matthew) |
| Filing 147 Letter/request (non-motion) from BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation, Requesting Clarification on 145 Court's Ruling on Plaintiffs' Motion in Limine No. 2. (Jones, Phyllis) |
| Filing 146 MOTION for Hearing by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation.(Jones, Phyllis) |
| Filing 145 Judge William G. Young: ELECTRONIC ORDER entered granting #135 MOTION in Limine #2 REGARDING THE TRIAL TESTIMONY OF DEFENDANTS DESIGNATED EMPLOYEE WITNESSES. (Paine, Matthew) |
| Filing 144 Judge William G. Young: ELECTRONIC ORDER entered re #118 MOTION in Limine #1 to Exclude Defendants' Experts' Testimony on Label Adequacy.Motion denied. The witnesses may, of course, be cross-examined on the inadequacy of their earlier reports. (Paine, Matthew) |
| Filing 143 Opposition re #119 MOTION in Limine No. 6 to Exclude Testimony of Plaintiffs' Untimely Disclosed Witnesses and Limit Deposition Designations filed by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B)(Lurie, Michael) |
| Filing 142 Fourth MOTION in Limine to admit the Past Recollection Recorded Video Testimony of Dr. Julia Song by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Robertson, Rebecca) |
| Filing 141 MOTION in Limine # 3 FOR THE IMPOSITION OF SANCTIONS STEMMING FROM DEFENDANTS EXTRAORDINARY DISCOVERY MISCONDUCT by Emily Liu, Li Liu. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8)(Lurie, Michael) |
| Filing 140 REPLY to Response to #105 MOTION in Limine No. 5 to Exclude Evidence of Irrelevant Company Conduct, Litigation, and Financial Matters filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Jones, Phyllis) |
| Filing 139 Judge William G. Young: ELECTRONIC ORDER entered granting #137 MOTION for Leave to File Reply Brief in Support of Defendants' Motion in Limine No. 5 ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
| Filing 138 Opposition re #118 MOTION in Limine #1 to Exclude Defendants' Experts' Testimony on Label Adequacy filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Jones, Phyllis) |
| Filing 137 MOTION for Leave to File Reply Brief in Support of Defendants' Motion in Limine No. 5 to Exclude Evidence of Irrelevant Company Conduct, Litigation, and Financial Matters (Unopposed) by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation.(Jones, Phyllis) |
| Filing 136 MOTION in Limine No. 7 to Exclude Evidence or Argument Concerning Preempted Claims Relating to "Black Box" Warnings and Contraindications by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F)(Jones, Phyllis) |
| Filing 135 MOTION in Limine #2 REGARDING THE TRIAL TESTIMONY OF DEFENDANTS DESIGNATED EMPLOYEE WITNESSES by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B)(Lurie, Michael) |
| Filing 134 REPLY to Response to #98 MOTION in Limine No. 3 to Exclude Evidence or Argument Related to Pradaxa's Initial Lack of a Reversal Agent and Subsequent Approval of a Reversal Agent filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(Jones, Phyllis) |
| Filing 133 REPLY to Response to #97 MOTION in Limine No. 2 to Exclude Argument and Evidence Related to Pradaxa Blood Plasma Concentrations filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B)(Jones, Phyllis) |
| Filing 132 REPLY to Response to #96 MOTION in Limine No. 1 to Exclude Evidence Related to the 110 Milligram Dose of Pradaxa filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Jones, Phyllis) |
| Filing 131 Electronic Clerk's Notes for proceedings held before Judge William G. Young: Final Pretrial Conference held (lobby) on 5/17/2017. The Court inquires as to settlement. Jury trial expected to last 20 days to begin on Monday, June 12, 2017 at 9:00 AM. The Court reviews the dates he will not sit on trial and reviews procedures of the session; i.e. empanelment, exhibit numbering/lettering, time limits for openings/closings. The Court Orders that plaintiffs' designations are to be filed on or before 5/22/2017 with counter designations/objections due one week after receipt. The Court entertains questions from counsel and informs counsel that if the case were to settle, they should notify the clerk. (Jury Trial Day One set for 6/12/2017 09:00 AM, Jury Trial Day Two set for 6/13/2017 09:00 AM, Jury Trial Day Three set for 6/19/2017 09:00 AM, Jury Trial Day Four set for 6/20/2017 09:00 AM, Jury Trial Day Five set for 6/21/2017 09:00 AM, Jury Trial Day Six set for 6/23/2017 09:00 AM, Jury Trial Day Seven set for 6/26/2017 09:00 AM, Jury Trial Day Eight set for 6/27/2017 09:00 AM, Jury Trial Day Nine set for 6/28/2017 09:00 AM in Courtroom 18 before Judge William G. Young.) (Court Reporter: None.)(Attorneys present: Attorneys Lurie and Macdonald for the plaintiffs, Attorneys Jones and Flanagan for the defendants) (Gaudet, Jennifer) |
| Filing 130 First Opposition re #105 MOTION in Limine No. 5 to Exclude Evidence of Irrelevant Company Conduct, Litigation, and Financial Matters filed by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Robertson, Rebecca) |
| Filing 129 Judge William G. Young: ELECTRONIC ORDER entered granting #126 Motion for Leave to File Reply ; granting #127 Motion for Leave to File Reply.; granting #128 Motion for Leave to File Reply ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
| Filing 128 MOTION for Leave to File Reply Brief in Support of Defendants' Motion in Limine No. 3 to Exclude Evidence or Argument Related to Pradaxa's Initial Lack of a Reversal Agent and Subsequent Approval of a Reversal Agent (Unopposed) by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation.(Jones, Phyllis) |
| Filing 127 MOTION for Leave to File Reply Brief in Support of Defendants' Motion in Limine No. 2 to Exclude Argument and Evidence Related to Pradaxa Blood Plasma Concentrations (Unopposed) by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation.(Jones, Phyllis) |
| Filing 126 MOTION for Leave to File Reply Brief in Support of Defendants' Motion in Limine No. 1 to Exclude Evidence Related to the 110 Milligram Dose of Pradaxa (Unopposed) by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation.(Jones, Phyllis) |
| Filing 125 Objections to Plaintiffs' Proposed Exhibits by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation (Jones, Phyllis) (Modified on 5/17/2017 to Correct Docket Text) (Paine, Matthew). |
| Filing 124 Letter/request (non-motion) from Michael D. Lurie to Atty Phyllis Jones re Compliance with April 11, 2017 Procedural Order re: Pretrial Conference. (Lurie, Michael) |
| Filing 123 REPLY to Response to #100 MOTION in Limine No. 4 to Exclude the Expert Testimony of Dr. Walter J. Molofsky filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Jones, Phyllis) |
| Filing 122 Judge William G. Young: ELECTRONIC ORDER entered granting #121 MOTION for Leave to File Reply Brief in Support of Defendants' Motion in Limine No. 4 ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
| Filing 121 MOTION for Leave to File Reply Brief in Support of Defendants' Motion in Limine No. 4 to Exclude the Expert Testimony of Dr. Walter J. Molofsky (Unopposed) by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit 1 (Proposed Reply Brief))(Jones, Phyllis) |
| Filing 120 ELECTRONIC NOTICE issued requesting courtesy copy for #118 MOTION in Limine #1 to Exclude Defendants' Experts' Testimony on Label Adequacy, #119 MOTION in Limine No. 6 to Exclude Testimony of Plaintiffs' Untimely Disclosed Witnesses and Limit Deposition Designations. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office attention Matthew Paine Docket Clerk Judge Young. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
| Filing 119 MOTION in Limine No. 6 to Exclude Testimony of Plaintiffs' Untimely Disclosed Witnesses and Limit Deposition Designations by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Jones, Phyllis) |
| Filing 118 MOTION in Limine #1 to Exclude Defendants' Experts' Testimony on Label Adequacy by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M)(Lurie, Michael) |
| Filing 117 MEMORANDUM in Opposition re #98 MOTION in Limine No. 3 to Exclude Evidence or Argument Related to Pradaxa's Initial Lack of a Reversal Agent and Subsequent Approval of a Reversal Agent filed by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Lurie, Michael) |
| Filing 116 MEMORANDUM in Opposition re #97 MOTION in Limine No. 2 to Exclude Argument and Evidence Related to Pradaxa Blood Plasma Concentrations filed by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Lurie, Michael) |
| Filing 115 MEMORANDUM in Opposition re #96 MOTION in Limine No. 1 to Exclude Evidence Related to the 110 Milligram Dose of Pradaxa filed by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Lurie, Michael) |
| Filing 114 ELECTRONIC NOTICE issued requesting courtesy copy for #112 Memorandum in Opposition to Motion, #113 Affidavit in Opposition,. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by attention Matthew Paine Docket Clerk Judge Young. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
| Filing 113 AFFIDAVIT in Opposition re #100 MOTION in Limine No. 4 to Exclude the Expert Testimony of Dr. Walter J. Molofsky, #112 Memorandum in Opposition to Motion, . (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15)(Lurie, Michael) |
| Filing 112 MEMORANDUM in Opposition re #100 MOTION in Limine No. 4 to Exclude the Expert Testimony of Dr. Walter J. Molofsky filed by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Appendix A)(Lurie, Michael) |
| Filing 111 Judge William G. Young: ELECTRONIC ORDER entered denying #110 First Motion for Leave to File Excess Pages (Paine, Matthew) |
| Filing 110 First MOTION for Leave to File Excess Pages in Response to Motion in Limine #4 (UNOPPOSED) by Emily Liu, Li Liu.(Lurie, Michael) |
| Filing 109 Judge William G. Young: ELECTRONIC ORDER entered re #108 Assented to MOTION to Seal Document s to be Filed in Support of Plaintiffs' Oppositions to Defendants' Motions in Limine Nos. 1-4.Motion denied. Nothing is to be filed under seal save actual and acknowledge trade secrets. (Paine, Matthew) |
| Filing 108 Assented to MOTION to Seal Document s to be Filed in Support of Plaintiffs' Oppositions to Defendants' Motions in Limine Nos. 1-4 by Emily Liu, Li Liu.(Lurie, Michael) |
| Filing 107 Judge William G. Young: ELECTRONIC ORDER entered granting #106 Motion for Extension of Time to File Response/Reply re #100 MOTION in Limine No. 4 to Exclude the Expert Testimony of Dr. Walter J. Molofsky, #97 MOTION in Limine No. 2 to Exclude Argument and Evidence Related to Pradaxa Blood Plasma Concentrations, #96 MOTION in Limine No. 1 to Exclude Evidence Related to the 110 Milligram Dose of Pradaxa, #98 MOTION in Limine No. 3 to Exclude Evidence or Argument Related to Pradaxa's Initial Lack of a Reversal Agent and Subsequent Approval of a Reversal Agent Responses due by 5/12/2017 (Paine, Matthew) |
| Filing 106 First MOTION for Extension of Time to 05/12/17 to File Response/Reply as to #98 MOTION in Limine No. 3 to Exclude Evidence or Argument Related to Pradaxa's Initial Lack of a Reversal Agent and Subsequent Approval of a Reversal Agent, #97 MOTION in Limine No. 2 to Exclude Argument and Evidence Related to Pradaxa Blood Plasma Concentrations, #96 MOTION in Limine No. 1 to Exclude Evidence Related to the 110 Milligram Dose of Pradaxa, #100 MOTION in Limine No. 4 to Exclude the Expert Testimony of Dr. Walter J. Molofsky by Emily Liu, Li Liu.(Lurie, Michael) |
| Filing 105 MOTION in Limine No. 5 to Exclude Evidence of Irrelevant Company Conduct, Litigation, and Financial Matters by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F)(Jones, Phyllis) |
| Filing 104 Judge William G. Young: ELECTRONIC ORDER entered granting #102 Motion for Leave to Appear Pro Hac Vice. Added Kathleen Paley. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Paine, Matthew) |
| Filing 103 PRETRIAL MEMORANDUM by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Jones, Phyllis) |
| Filing 102 MOTION for Leave to Appear Pro Hac Vice for admission of Kathleen Paley Filing fee: $ 100, receipt number 0101-6604350 by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A-Certification of Kathleen Paley)(Carpenter, Curtis) |
| Filing 101 ELECTRONIC NOTICE issued requesting courtesy copy for #100 MOTION in Limine No. 4 to Exclude the Expert Testimony of Dr. Walter J. Molofsky. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office attention Matthew Paine Docket Clerk Judge Young. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
| Filing 100 MOTION in Limine No. 4 to Exclude the Expert Testimony of Dr. Walter J. Molofsky by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K)(Jones, Phyllis) |
| Filing 99 ELECTRONIC NOTICE issued requesting courtesy copy for #98 MOTION in Limine No. 3 to Exclude Evidence or Argument Related to Pradaxa's Initial Lack of a Reversal Agent and Subsequent Approval of a Reversal Agent, #97 MOTION in Limine No. 2 to Exclude Argument and Evidence Related to Pradaxa Blood Plasma Concentrations, #96 MOTION in Limine No. 1 to Exclude Evidence Related to the 110 Milligram Dose of Pradaxa. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office attention Matthew Paine Docket Clerk Judge Young. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Paine, Matthew) |
| Filing 98 MOTION in Limine No. 3 to Exclude Evidence or Argument Related to Pradaxa's Initial Lack of a Reversal Agent and Subsequent Approval of a Reversal Agent by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Jones, Phyllis) |
| Filing 97 MOTION in Limine No. 2 to Exclude Argument and Evidence Related to Pradaxa Blood Plasma Concentrations by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H)(Jones, Phyllis) |
| Filing 96 MOTION in Limine No. 1 to Exclude Evidence Related to the 110 Milligram Dose of Pradaxa by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GMBH, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I)(Jones, Phyllis) |
| Filing 95 Judge William G. Young: ORDER entered. PROCEDURAL ORDER re pretrial/trial. Final Pretrial Conference set for 5/17/2017 02:00 PM in Courtroom 18 before Judge William G. Young.(Gaudet, Jennifer) |
| Filing 94 Judge William G. Young: ORDER entered. MEMORANDUM OF DECISION: For the foregoing reasons, this Court on October 18, 2016, GRANTED IN PART and DENIED IN PART the Defendants motion forsummary judgment, ECF No. #41 . Summary judgment is GRANTED as to the claims of negligent design and testing; it is DENIED as to the adequacy of Pradaxas label and proximate cause.(Paine, Matthew) |
| Filing 93 Judge William G. Young: ELECTRONIC ORDER entered re #90 MOTION to Establish Pretrial Scheduling Deadlines and Leave to Make Supplemental Expert Disclosures.Denied. Discovery is now closed save for good cause shown. Pre-Trial events will proceed in the ordinary course. (Paine, Matthew) |
| Filing 92 EXHIBIT re #91 Opposition to Motion, by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: # (I) Exhibit I, #2 Exhibit J)(Flanagan, William) |
| Filing 91 Opposition re #90 MOTION to Establish Pretrial Scheduling Deadlines and Leave to Make Supplemental Expert Disclosures filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G)(Flanagan, William) |
| Filing 90 MOTION to Establish Pretrial Scheduling Deadlines and Leave to Make Supplemental Expert Disclosures by Emily Liu, Li Liu.(Lurie, Michael) |
| Filing 89 NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at #http://www.mad.uscourts.gov/attorneys/general-info.htm (Scalfani, Deborah) |
| Filing 88 Transcript of Summary Judgment Hearing held on October 13, 2016, before Judge William G. Young. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Richard Romanow at bulldog@richromanow.com Redaction Request due 12/20/2016. Redacted Transcript Deadline set for 12/30/2016. Release of Transcript Restriction set for 2/27/2017. (Scalfani, Deborah) |
| Filing 87 Judge William G. Young: ELECTRONIC ORDER entered: Allowed as amended by the defendants' response re #84 MOTION to Amend Order Concerning the Deposition of Walter Molofsky, M.D. Due to Change in Assigned Trial List Month from December 2016 to June 2017. (Paine, Matthew) |
| Filing 86 ADDENDUM re #84 MOTION to Amend Order Concerning the Deposition of Walter Molofsky, M.D. Due to Change in Assigned Trial List Month from December 2016 to June 2017 filed by Emily Liu, Li Liu. (Attachments: #1 Exhibit)(Lurie, Michael) |
| Filing 85 RESPONSE to Motion re #84 MOTION to Amend Order Concerning the Deposition of Walter Molofsky, M.D. Due to Change in Assigned Trial List Month from December 2016 to June 2017 filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A email correspondence)(Flanagan, William) |
| Filing 84 MOTION to Amend Order Concerning the Deposition of Walter Molofsky, M.D. Due to Change in Assigned Trial List Month from December 2016 to June 2017 by Emily Liu, Li Liu.(Lurie, Michael) |
| Filing 83 ELECTRONIC NOTICE Canceling Hearing. The final pretrial conference scheduled for Wednesday, November 16, 2016 at 2:30 PM is hereby canceled. A final pretrial conference will be set for May 2017 under separate notice. (Gaudet, Jennifer) |
| Filing 82 Judge William G. Young: ELECTRONIC ORDER entered: The case is continued to the June, 2017 trial list. There shall be no further continuances. The motion is otherwise denied, save that the denial of the motion to compel is without prejudice to its renewal should the plaintiffs, upon the excercise of due diligence, not be able to obtain copies of Boehringer Ingelheim's state court disclosures. The defendant's are, of course, precluded from offering or referring to any of these undisclosed documents, or basing expert testimony thereon. Ready for Trial on 6/5/2017 09:00 AM in Courtroom 18 before Judge William G. Young.(Paine, Matthew) |
| Filing 81 Opposition re #74 First MOTION to Compel Production of DocumentsFirst MOTION to Continue Trial to June 5, 2017 and Amend Scheduling Order to Permit Plaintiffs to Review New Document Production of 2.1 Million Pages filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A - Joint Local Rule 16 1 Scheduling Conference Statement (Nov 19 2015), #2 Exhibit B - CMO 95 (May 13 2015), #3 Exhibit C - Email to Plaintiffs counsel (Jan 8 2016), #4 Exhibit D - Email to Plaintiffs counsel (Feb 19 2016), #5 Exhibit E - Email from Plaintiffs counsel (Aug 31 2016), #6 Exhibit F - Email to Plaintiffs counsel (Sept 26 2016), #7 Exhibit G - Email to Plaintiffs counsel (Oct 4 2016), #8 Exhibit H - Email from Plaintiffs counsel (Oct 6 2016), #9 Exhibit I - Email from Plaintiffs counsel (Nov 1 2016), #10 Exhibit J - Email to Plaintiffs counsel (Oct 20 2016), #11 Exhibit K - Liu Remand Order (May 18 2015))(Flanagan, William) |
| Filing 80 Judge William G. Young: ELECTRONIC ORDER entered granting #79 Motion for Leave to Appear Pro Hac Vice Added Phyllis A. Jones. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Paine, Matthew) |
| Filing 79 MOTION for Leave to Appear Pro Hac Vice for admission of Phyllis A. Jones Filing fee: $ 100, receipt number 0101-6369009 by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A--Certification of Attorney Jones)(Carpenter, Curtis) |
| Filing 78 PRETRIAL MEMORANDUM by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Flanagan, William) |
| Filing 77 EXHIBIT re #74 First MOTION to Compel Production of DocumentsFirst MOTION to Continue Trial to June 5, 2017 and Amend Scheduling Order to Permit Plaintiffs to Review New Document Production of 2.1 Million Pages Exhibit B refiled by Emily Liu, Li Liu. (Lurie, Michael) |
| Filing 76 Judge William G. Young: ELECTRONIC ORDER entered re #75 MOTION to Seal Document filed as Exhibit B to Plaintiff's Motion to Compel and Continue (#74) and to Withdraw Document from Public Docket.The document may be withdrawn. No adequate showing, however, has been made concerning why this document needs to be filed under seal. (Paine, Matthew) |
| Filing 75 MOTION to Seal Document filed as Exhibit B to Plaintiff's Motion to Compel and Continue (#74) and to Withdraw Document from Public Docket by Emily Liu, Li Liu.(Lurie, Michael) |
| Filing 74 First MOTION to Compel Production of Documents, First MOTION to Continue Trial to June 5, 2017 and Amend Scheduling Order to Permit Plaintiffs to Review New Document Production of 2.1 Million Pages ( Responses due by 11/11/2016) by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Affidavit of Alex H. MacDonald)(Lurie, Michael) (Attachment 2 replaced on 11/1/2016) (Paine, Matthew). |
| Filing 73 Judge William G. Young: ELECTRONIC ORDER entered granting #63 MOTION to Compel Deposition of the Plaintiffs expert witness, Dr. Walter Molofsky. MOTION ALLOWED. Dr. Molofsky shall be produced for the taking of his deposition within 30 days of the date of this order. (Paine, Matthew) |
| Filing 72 ELECTRONIC NOTICE OF RESCHEDULING. Final Pretrial Conference reset for 11/16/2016 02:30 PM in Courtroom 18 before Judge William G. Young. (Gaudet, Jennifer) |
| Filing 71 Judge William G. Young: ORDER entered granting in part and denying in part #41 Motion for Summary Judgment (Paine, Matthew) |
| Filing 70 Notice of Supplemental Authorities re #41 MOTION for Summary Judgment (Attachments: #1 Exhibit A)(Flanagan, William) |
| Filing 69 Judge William G. Young: ELECTRONIC ORDER entered granting #66 MOTION for Leave to File to File Notice of Supplemental Authority in Support of Motion for Summary Judgment ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
| Filing 68 AFFIDAVIT of Molofsky filed by Emily Liu, Li Liu. (Gaudet, Jennifer) |
| Filing 67 Electronic Clerk's Notes for proceedings held before Judge William G. Young: Motion Hearing held on 10/13/2016 re #41 MOTION for Summary Judgment filed by Boehringer Ingelheim USA Corporation, Boehringer Ingelheim Corporation, BOEHRINGER INGELHEIM PHARMACEUTICALS INC. The Court hears oral arguments on pending motion and takes the matter under advisement. The plaintiff moves orally to file Molofsky Affidavit which was erroneously omitted from a previous filing - motions allowed. (Court Reporter: Richard Romanow at bulldog@richromanow.com.)(Attorneys present: Lurie and MacDonald for the plaintiffs, Imbroscio and Glanagan for the defendant) (Gaudet, Jennifer) |
| Filing 66 MOTION for Leave to File to File Notice of Supplemental Authority in Support of Motion for Summary Judgment by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation.(Flanagan, William) |
| Filing 65 Objection to #56 Notice of Supplemental Authorities, #55 Notice of Supplemental Authorities by Emily Liu, Li Liu . (Lurie, Michael) |
| Filing 64 Judge William G. Young: ELECTRONIC ORDER entered granting #61 MOTION for Leave to File OBJECTION TO DEFENDANTS NOTICE OF SUPPLEMENTAL AUTHORITY AND AMENDED NOTICE OF SUPPLEMENTAL AUTHORITY IN SUPPORT OF DEFENDANTS MOTION FOR SUMMARY JUDGMENT ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Paine, Matthew) |
| Filing 63 MOTION to Compel Deposition of the Plaintiffs expert witness, Dr. Walter Molofsky by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Certification Pursuant to Local Rule 7.1(a)(2))(Flanagan, William) |
| Filing 62 Judge William G. Young: ELECTRONIC ORDER entered denying #51 Motion to Strike (Paine, Matthew) |
| Filing 61 MOTION for Leave to File OBJECTION TO DEFENDANTS NOTICE OF SUPPLEMENTAL AUTHORITY AND AMENDED NOTICE OF SUPPLEMENTAL AUTHORITY IN SUPPORT OF DEFENDANTS MOTION FOR SUMMARY JUDGMENT by Emily Liu, Li Liu.(Lurie, Michael) |
| Filing 60 Opposition re #51 MOTION to Strike #47 Affidavit of Dr. Molofsky Submitted by Plaintiffs in Opposition to Defendants Motion for Summary Judgment filed by Emily Liu, Li Liu. (Lurie, Michael) |
| Filing 59 Judge William G. Young: ORDER entered. PROCEDURAL ORDER re pretrial/trial. Final Pretrial Conference set for 11/17/2016 02:00 PM in Courtroom 18 before Judge William G. Young.(Gaudet, Jennifer) |
| Filing 58 Judge William G. Young: ELECTRONIC ORDER entered granting #54 Assented-to Motion to Correct Affidavit of Walter J. Molofsky. (Paine, Matthew) |
| Filing 57 Judge William G. Young: ELECTRONIC ORDER entered granting #53 Motion for Leave to Appear Pro Hac Vice. Added Michael X. Imbroscio. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Paine, Matthew) |
| Filing 56 Amended Notice of Supplemental Authorities re #41 MOTION for Summary Judgment (Attachments: #1 Niedner Decision)(Flanagan, William) |
| Filing 55 Notice of Supplemental Authorities re #41 MOTION for Summary Judgment (Attachments: #1 Exhibit Niedner Decision)(Flanagan, William) |
| Filing 54 Assented to MOTION to Correct #47 Affidavit of Walter J. Molofsky, Exhibit 1, Document 47-1 by Emily Liu, Li Liu. (Attachments: #1 Exhibit 1)(Lurie, Michael) |
| Filing 53 MOTION for Leave to Appear Pro Hac Vice for admission of Michael X. Imbroscio Filing fee: $ 100, receipt number 0101-6324303 by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A--Certification of Attorney Imbroscio)(Carpenter, Curtis) |
| Filing 52 MEMORANDUM in Support re #51 MOTION to Strike #47 Affidavit of Dr. Molofsky Submitted by Plaintiffs in Opposition to Defendants Motion for Summary Judgment filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Carpenter, Curtis) |
| Filing 51 MOTION to Strike #47 Affidavit of Dr. Molofsky Submitted by Plaintiffs in Opposition to Defendants Motion for Summary Judgment by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A--Molofsky Expert Report)(Flanagan, William) |
| Filing 50 REPLY to Response to #41 MOTION for Summary Judgment filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit A--Molofsky Expert Report, #2 Exhibit B--Bilazarian Dep Excerpts, #3 Exhibit C--Li Liu Dep Excerpts, #4 Exhibit D--Emily Liu Dep Excerpts)(Flanagan, William) |
| Filing 49 NOTICE of Appearance by Michael D. Lurie on behalf of Emily Liu, Li Liu (Lurie, Michael) |
| Filing 48 AFFIDAVIT of Emily Liu, M.D. re #46 Memorandum in Opposition to Motion for Summary Judgment by Emily Liu, Li Liu. (Lurie, Michael) |
| Filing 47 AFFIDAVIT of Walter J. Molofsky, M.D. re #46 Memorandum in Opposition to Motion for Summary Judgment by Emily Liu, Li Liu. (Attachments: #1 Exhibit A)(Lurie, Michael) |
| Filing 46 MEMORANDUM in Opposition re #41 MOTION for Summary Judgment filed by Emily Liu, Li Liu. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Lurie, Michael) |
| Filing 45 Judge William G. Young: ELECTRONIC ORDER entered granting #40 Motion for Leave to Appear Pro Hac Vice. Added Paul W. Schmidt. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Paine, Matthew) |
| Filing 44 ELECTRONIC NOTICE issued requesting courtesy copy for #42 Memorandum in Support of Motion,,. Counsel who filed this document are requested to submit a courtesy copy of this document (or documents) to the Clerk's Office by 9/9/2016. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Gaudet, Jennifer) |
| Filing 43 ELECTRONIC NOTICE Setting Hearing on Motion #41 MOTION for Summary Judgment : Motion Hearing set for 10/13/2016 02:00 PM in Courtroom 18 before Judge William G. Young. (Gaudet, Jennifer) |
| Filing 42 MEMORANDUM in Support re #41 MOTION for Summary Judgment filed by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit Pradaxa Prescribing Information (Oct. 2010), #2 Exhibit Excerpts from Deposition of Dr. Seth Bilazarian, #3 Exhibit Letter from Richard Pazdur to Michelle Kliewer, Biologics License Application Accelerated Approval (Oct. 16, 2015), #4 Exhibit Excerpts from Deposition of Dr. Emily Liu)(Flanagan, William) |
| Filing 41 MOTION for Summary Judgment by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation.(Flanagan, William) |
| Filing 40 MOTION for Leave to Appear Pro Hac Vice for admission of Paul W. Schmidt Filing fee: $ 100, receipt number 0101-6268531 by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit Certification of Paul W. Schmidt)(Carpenter, Curtis) |
| Filing 39 ELECTRONIC NOTICE Canceling Telephone conference and ADR Hearing. The parties have informed the court that they are going to private a private mediator. (Garvin, Brendan) |
| Filing 38 ELECTRONIC NOTICE of Hearing. Telephone Conference set for 8/10/2016 02:45 PM in Courtroom 25 before Magistrate Judge Marianne B. Bowler. Counsel wishing to be heard may participate by calling 888-675-2535 and entering Access Code - 6641794 and Security Code 10932. Counsel are advised to dial in to the teleconference number five minutes before the hearing. (Garvin, Brendan) |
| Filing 37 ELECTRONIC NOTICE OF RESCHEDULING Alternative Dispute Resolution Hearing set for 9/20/2016 10:00 AM in Courtroom 25 before Magistrate Judge Marianne B. Bowler. See prior notice regarding rules and regulations of ADR in this session.(Garvin, Brendan) |
| Filing 36 CORPORATE DISCLOSURE STATEMENT by Boehringer Ingelheim International GMBH identifying Corporate Parent Boehringer Ingelheim Verwaltungs GmbH for Boehringer Ingelheim International GMBH.. (Carpenter, Curtis) |
| Filing 35 ANSWER to #1 Complaint with Jury Demand by Boehringer Ingelheim International GMBH.(Carpenter, Curtis) |
| Filing 34 Judge William G. Young: ORDER entered: CONFIDENTIALITY ORDER as modified (Attachments: #1 Exhibit A)(Paine, Matthew) |
| Filing 33 Judge William G. Young: ELECTRONIC ORDER entered granting #32 Motion for Protective Order (Paine, Matthew) |
| Filing 32 MOTION for Protective Order by BOEHRINGER INGELHEIM PHARMACEUTICALS INC.. (Attachments: #1 Exhibit A)(Carpenter, Curtis) |
| Filing 31 ELECTRONIC NOTICE of ADR Conference Alternative Dispute Resolution Hearing set for 9/5/2016 10:00 AM in Courtroom 25 before Magistrate Judge Marianne B. Bowler. Counsel and principals are ORDERED to be present and to have full settlement authority. A brief mediation memorandum addressing both the merits of the case and the filing party's settlement position should be submitted to the court via facsimile to (617) 204-5833 or via email as an attachment to Christine_Patton@mad.uscourts.gov THREE BUSINESS DAYS before the hearing. The mediation memo should be marked "Confidential - Not for docketing" and is not to be served upon opposing parties. Counsel are asked to accommodate this date. In the event that you believe the case is not ripe for mediation at this time contact the Courtroom Deputy. But if the date poses a serious conflict, please do NOT contact the Courtroom Deputy directly regarding mediation scheduling. Counsel are to confer with opposing counsel and FILE AN ASSENTED-TO MOTION TO CONTINUE the mediation, including therein several proposed dates for which all counsel and principals are available. (Garvin, Brendan) |
| Filing 30 Notice of assignment to ADR Provider. Judge Marianne B. Bowler appointed.(Garvin, Brendan) |
| Filing 29 REFERRING CASE to Alternative Dispute Resolution as of Septmber 2016.(Paine, Matthew) |
| Filing 28 Electronic Clerk's Notes for proceedings held before Judge William G. Young: Scheduling Conference held on 11/20/2015. The Court explains the requirements of the session. The parties do not want to proceed before a magistrate judge. The case is to go to ADR during the month of September 2016 and is placed on the running trial list for December 2016. A final pretrial conference will be set for the month of November 2016. A joint pretrial memo is due the first Monday of the month preceding the trial month. Any motions for summary judgment shall be filed atleast three (3) months prior to trial month. (Ready for Trial on 12/5/2016 09:00 AM in Courtroom 18 before Judge William G. Young.) (Court Reporter: No Court Reporter Used.) (Gaudet, Jennifer) |
| Filing 27 Judge William G. Young: ORDER entered. re #25 JOINT STATEMENT is so ordered as modified as the case management scheduling order. DISCOVERY DUE October 24, 2016 and DISPOSITIVE MOTIONS DUE September 1, 2016. (Paine, Matthew) |
| Filing 26 Judge William G. Young: ELECTRONIC ORDER entered denying #22 Motion to Continue. The clerk has confirmed with counsel that another attorney of record for the plaintiff can appear at the hearing. (Gaudet, Jennifer) |
| Filing 25 First JOINT STATEMENT re scheduling conference . (Attachments: #1 Exhibit, #2 Exhibit)(MacDonald, Alex) |
| Filing 24 Judge William G. Young: ELECTRONIC ORDER entered granting #23 Motion for Leave to Appear Pro Hac Vice. Added Eric E. Hudson. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Paine, Matthew) |
| Filing 23 MOTION for Leave to Appear Pro Hac Vice for admission of Eric E. Hudson Filing fee: $ 100, receipt number 0101-5829795 by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit)(Carpenter, Curtis) |
| Filing 22 First MOTION to Continue Status Conference to December 23, 2015 by Emily Liu, Li Liu. (Attachments: #1 Exhibit)(MacDonald, Alex) |
| Filing 21 NOTICE of Scheduling Conference. Scheduling Conference set for 11/20/2015 02:00 PM in Courtroom 18 before Judge William G. Young. (Gaudet, Jennifer) |
| Filing 20 CORPORATE DISCLOSURE STATEMENT by BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Flanagan, William) |
| Filing 19 ANSWER to #1 Complaint with Jury Demand by Boehringer Ingelheim USA Corporation.(Flanagan, William) |
| Filing 18 ANSWER to #1 Complaint with Jury Demand by Boehringer Ingelheim Corporation.(Flanagan, William) |
| Filing 17 ANSWER to #1 Complaint with Jury Demand by BOEHRINGER INGELHEIM PHARMACEUTICALS INC..(Flanagan, William) |
| Filing 16 NOTICE of Appearance by William J. Flanagan on behalf of Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation (Flanagan, William) |
| Filing 15 NOTICE of Appearance by Curtis L.S. Carpenter on behalf of BOEHRINGER INGELHEIM PHARMACEUTICALS INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation (Carpenter, Curtis) |
| Case reopened. (Nicewicz, Craig) |
| Filing 14 Case remanded from from District of Illinois (Southern); Case Number 14cv60039. (Paine, Matthew) |
| Filing 12 NOTICE of Appearance by William J. Flanagan on behalf of BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (Flanagan, William) |
| Filing 11 NOTICE of Appearance by Alex H. MacDonald on behalf of Emily Liu, Li Liu (MacDonald, Alex) |
| Filing 10 NOTICE of Appearance by Michael D. Lurie on behalf of Emily Liu, Li Liu (Lurie, Michael) |
| Filing 9 NOTICE of Appearance by William J. Flanagan on behalf of BOEHRINGER INGELHEIM PHARMACEUTICALS INC.. (Flanagan, William) (Modified on 6/2/2015 to Correct Docket Text) (Paine, Matthew). |
| Filing 8 MDL Conditional Remand Order from the Southern District of Illinois; Case Number 14-60039. (Jones, Sherry) |
| Filing 7 Electronic notice to counsel: This civil action has been transferred to the Southern District of Illinois and assigned civil case number 3:14-cv-60039. (Abaid, Kimberly) |
| Filing 6 Case transferred to to District of Illinois (Southern) pursuant to Conditional Transfer Order entered by the MDL Panel on August 18, 2014. Case file electronically transferred to the Clerk in that district. (Paine, Matthew) |
| Filing 5 Certified copy of MDL Conditional Transfer Order number 69 in MDL Case 2385 received from District of Illinois (Southern) requesting transfer of case for consolidated pretrial proceedings (Paine, Matthew) |
| Filing 4 Informational copy of MDL Conditional Transfer Order number 69 in MDL Case 2385 received from the mdl panel requesting transfer of case for consolidated pretrial proceedings. (Jones, Sherry) |
| Filing 3 Summons Issued as to All Defendants. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (Burgos, Sandra) |
| Filing 2 ELECTRONIC NOTICE of Case Assignment. Judge William G. Young assigned to case. If the trial Judge issues an Order of Reference of any matter in this case to a Magistrate Judge, the matter will be transmitted to Magistrate Judge Judith G. Dein. (Abaid, Kimberly) |
| Filing 1 COMPLAINT against All Defendants Filing fee: $ 400, receipt number 0101-5134655 (Fee Status: Filing Fee paid), filed by Emily Liu, Li Liu. (Attachments: #1 Civil Cover Sheet, #2 Civil Category Sheet)(Robertson, Rebecca) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Massachusetts District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
